Steve Satek, MBA

President and Co-Founder

Satek 2017.jpg

Steve brings more than 25 years of research experience to Great Lakes Clinical Trials. He began his career as a bench researcher at the Northwestern University Robert H. Lurie Cancer Center and since that time has held senior management positions at the Chicago Center for Clinical Research, Radiant Research, Cognitive Drug Research, Theivon-Wright Consulting Group and Forenap Pharma.  

Steve offers a diverse and thorough knowledge of clinical trial operations, which has been presented at over 20 industry conferences.  In addition, he has project managed and/or coordinated over 100 trials.  He holds two Bachelor of Science degrees in Molecular Biology and in Biochemistry from the University of Wisconsin-Madison and an Executive MBA from the Lake Forest Graduate School of Management. 


Dean Hervochon Executive Vice President and  Co-Founder Dean's vision and determination have been instrumental in the creation and success of Great Lakes Clinical Trials, the world-class, internationally-recognized research clinic where Dean serves as Co-Founder and Executive Vice President.

Dean Hervochon

Executive Vice President and  Co-Founder

Dean's vision and determination have been instrumental in the creation and success of Great Lakes Clinical Trials, the world-class, internationally-recognized research clinic where Dean serves as Co-Founder and Executive Vice President.

As a lifelong entrepreneur that had worked across many different industries, Dean brought "fresh-eyes" to the project of developing a clinical research facility that focuses on and addresses issues and challenges related to the most important component of any research initiative: potential participants. Dean refers to these participants as “Medical Heroes” because of the critical role that they play in bringing new therapies to market. He quickly understood the importance of recruiting, educating, enrolling and protecting these Medical Heroes.  Dean recognized that there was a distinct lack of minority participation in clinical trials that had become an industry-wide problem, especially for sites in the United States. Dean saw the situation as an opportunity to bring clinical research to those patient populations that are often the most affected by the disease states that Great Lakes studies. Dean’s focus, determination, and creativity have brought clinical trials to people that other clinics were not reaching while simultaneously benefiting sponsors by providing access to formerly untapped patient populations for participation in industry-sponsored trials. 

Dean's innovative and sometimes unconventional methods of recruiting and enrolling trial participants have resulted in Great Lakes Clinical Trials achieving a minority enrollment and retention rate that is among the highest in the world. As a recognized leader in patient recruitment strategies, Dean is a sought-after guest on radio talk shows and at political and social events. Industry sponsors have recognized Dean’s success and have enlisted him to present on unique and creative patient recruitment strategies at Investigator Meetings and conferences with a goal of assisting other sites in becoming more successful in their patient recruitment and enrollment efforts. As a result of Dean’s unrelenting perseverance and creativity in bringing clinical trials to diverse groups of patients, Great Lakes Clinical Trials was awarded the honor of being "The Hardest Working Site” in a recent ground-breaking Alzheimer's Disease trial.  

Dean has a bachelor’s degree in Labor Studies from Antioch University.  He has a strong background in labor advocacy and his extensive skills in this arena have been easily transferred to his work in patient recruitment and participant advocacy. As the First Vice President for the Transport Workers Union, Dean was instrumental in securing fair wages and better working conditions for the more than 6,000 workers during the many years that he represented them.  Dean has leveraged his leadership expertise and entrepreneurial spirit in shaping Great Lakes Clinical Trials into a world-leader in clinical research. The journey is just beginning and there is always work to be done to find cures and treatments for so many unmet medical needs.  The challenge is enormous, but not insurmountable.  Dean always says:  "Keep your blinders on..."


Jeffrey Ross, MD  

Medical Director

Dr. Jeff Ross is a board-certified psychiatrist who has conducted over 130 clinical trials across multiple disease areas including mood, anxiety, psychotic, cognitive (Alzheimer’s, MCI), sleep and substance abuse disorders. As an instructor of medical students and psychiatry residents at Chicago-area institutions (Northwestern University Medical School, Rush Medical College, Evanston Hospital, Illinois College of Optometry) over the past 20 years, Dr. Ross has provided ongoing medical education in both psychopharmacology and psychotherapy, equipping new physicians with important insights into the interviewing, care, & long-term management of patients with psychiatric illness.

Following his post-graduate fellowship in clinical psychopharmacology at Rush-Presbyterian-St.Luke’s Medical Center, Dr. Ross served as Medical Associate at Rush’s Treatment Research Center and Attending Psychiatrist at Rush-Presbyterian-St. Luke’s Medical Center, as well as Assistant Professor of Psychiatry Rush Medical College. As a board-certified psychiatrist, Dr. Ross maintains licensure in Illinois and continues to maintain his affiliation with the aforementioned academic centers. In addition, Dr. Ross’ private practice enables him to remain connected to the real world management of psychiatric illness.

From his extensive research experience, Dr. Ross has gained expertise in investigations across development phases (Phase I-IV), treatment settings (inpatient and outpatient), duration (short and long-term), trial design (open, blinded, acute therapy, relapse prevention), and intervention (psychotherapy and psychopharmacology). Aside from numerous peer-reviewed publications and lectures, Dr. Ross has also developed a particular niche providing psychiatric educational book reviews (Doody’s Health Sciences) for over a decade.


LInda Rice, PhD,

Neuropsychologist

Dr. Linda Rice is a Clinical Neuropsychologist with over 25 years of clinical, management and teaching experience.  She is a Diplomat of the American Board of Professional Psychology with a Clinical Neuropsychology Specialty.  Dr. Rice earned her PhD from Loyola University in Chicago, with an Internship at The Johns Hopkins University School of Medicine in Baltimore, Maryland and a Fellowship at the Sheppard & Enoch Pratt Hospital in Baltimore, Maryland.  She is currently enrolled in a Masters of Science program in Psychopharmacology at New Mexico State University.

Dr. Rice’s teaching experience includes an appointment on the Core Faculty at the Adler University in Chicago, overseeing the Military Psychology Track and Neuropsychology Concentration in the Doctor of Clinical Psychology Program.   Dr. Rice supervised advanced graduate students in the Neuropsychology Practicum, with the mission to provide neuropsychological services to underserved communities. Clinical supervision includes assessment of a wide variety of referrals from varied socioeconomic, ethnic, and cultural backgrounds. Common referral questions for these cases include differential diagnosis and treatment recommendations for traumatic brain injury, learning disorders/ADHD, seizure disorders, multiple sclerosis, psychiatric disorders, Alzheimer’s disease and other neurological disorders and dementia.

Dr. Rice developed her experience in Alzheimer’s disease assessment as a Neuropsychologist at the Sheppard & Enoch Pratt Hospital, in Towson, Maryland from 2000-2011.  As a consultant for the comprehensive Geriatric Service, she worked collaboratively to implement discharge planning that maximized appropriate care for dementia patients including consideration of caretaker needs.  She provided training and administration of CDR and ADAS-COG, and provided assessment of dementia and family education about coping with and managing dementia cognitive and behavioral issues. 

Additional specialties include:

  • Neuropsychological assessment of children and adults with Attention Deficit Hyperactivity Disorder and Learning Disorders at the Chesapeake ADHD Center of Maryland where she studied under Kathleen Nadeau, PhD, a nationally-recognized expert in the field.
  • Service Chief at the National Naval Medical Center in Bethesda, MD where she managed the hospital’s neuropsychology assessment clinic and provided neuropsychological assessment to referrals from the inpatient services and outpatient clinics.  Dr. Rice also provided cognitive rehabilitation for TBI patients in Wounded Warriors Program.
  • Providing Initial Assessment, Neuropsychological Assessment, and Cognitive Rehabilitation of patients on the Brain Injury Unit and general rehabilitation services at the Rehabilitation Institute of Chicago

Kevin C. Maki, PhD

Investigator, Nutrition and Metabolic Disorders

Dr. Maki is the Founder and Chief Science Officer for the MB Clinical Research (formerly Midwest Center for Metabolic and Cardiovascular Research) and serves as Investigator/Consultant on Great Lakes Clinical Trials' nutrition and metabolic research trials. He specializes in the design and conduct of clinical studies in human nutrition, metabolism and chronic disease risk factor management.

Dr. Makiholds an Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University. He is a certified Clinical Lipid Specialist and a Fellow of the National Lipid Association, The Obesity Society and the American College of Nutrition, as well as a member of the Board of Governors of the Accreditation Council for Clinical Lipidology. Dr. Maki has participated in more than 250 clinical trials and observational studies as an investigator, consultant or statistician, and published more than 200 scientific papers, books and book chapters. He earned a Ph.D. in Epidemiology from the University of Illinois at Chicago’s School of Public Health, and an M.S. in Preventive and Rehabilitative Cardiovascular Health from Benedictine University.